一般演題示説 第19分科会

[P19-13(30AM299)] Risk communication of safety information on nitrosamines to healthcare professionals.

*Hiroki Sugimori¹, Naoko Ito¹, Takeshi Odajima¹, Itsuko Horiguchi², Hiroaki Mamiya³, Takashi Ohira⁴, Kenichi Masumura⁵, Maki Hirao⁶, Masamitsu Honma⁵ (1. Daito Bunka University, Department of Nursing, Faculty of Sports & Health Science, 2. Keio University, School of Medicine, Graduate School of Medicine, 3. International University of Health and Welfare, Department of Pharmacy at Narita, 4. The Federation of Pharmaceutical Manufacturers’ Associations of JAPAN (Takeda Pharmaceutical Company Limited), 5. National Institute of Health Sciences, 6. Daito Bunka University, Department of Health Science, Faculty of Sports & Health Science)